Recursion Pharmaceuticals Aktie News
4,14 $
4,39 %
vorgestern
Nasdaq,
14. November, 22:19 Uhr
Was hinter der Kursbewegung steckt Beta
tracken
Recursion Pharmaceuticals Aktie News
Neutral
Seeking Alpha
●
10 Tage alt
Recursion Pharmaceuticals, Inc. ( RXRX ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Christopher Gibson - Co-Founder, CEO & Director Najat Khan - Chief R&D Officer, Chief Commercial Officer and Director Ben Taylor - CFO & President of Recursion UK Presentation Christopher Gibson Co-Founder, CEO & Director " Najat Khan Chief R&D Officer, Chief Commercial Officer and D...
Neutral
GlobeNewsWire
●
11 Tage alt
SALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and financial results for its third quarter ended September 30, 2025.
Neutral
GlobeNewsWire
●
11 Tage alt
Co-Founder and CEO Chris Gibson to Transition to Chairman of the Board; Najat Khan to be named Chief Executive Officer and President Co-Founder and CEO Chris Gibson to Transition to Chairman of the Board; Najat Khan to be named Chief Executive Officer and President
Positiv
The Motley Fool
●
12 Tage alt
Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins.
Neutral
GlobeNewsWire
●
12 Tage alt
Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences: Guggenheim 2nd Annual Healthcare Innovation Conference — Tuesday, November 11, 2025 Jefferies Global Healthcare Conference London — Tuesday, November 18,...
Neutral
The Motley Fool
●
16 Tage alt
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet.
Neutral
GlobeNewsWire
●
19 Tage alt
Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 financial results on Wednesday, November 5, 2025, before the open of the financial markets. Recursion will host a (L)earnings Call on November 5, 20...
Positiv
The Motley Fool
●
26 Tage alt
Many leading companies focused on artificial intelligence (AI) have seen their shares soar as they profit from the tailwind this market is currently experiencing. Perhaps a good way to cash in on this is to invest in smaller, under-the-radar players that don't attract nearly as much attention.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
